December 12th, 2012
AMPLIFYING Treatment for DVT/PE
John Ryan, MD
John Ryan reviews the latest data and suggests that DVT/PE be managed as a chronic condition. Are you using apixaban in these patients, and how long are you treating them for?
NEJM Journal Watch — Recent Cardiology Articles- Subcutaneous vs. Transvenous Implantable Cardioverter–Defibrillator: Which Is Better?
- The Week in COVID-19 Coverage
- Valve-in-Valve TAVR vs. Repeat Surgery for Aortic Bioprosthesis Failure
- Rosuvastatin Toxicity Observed After Use of Canagliflozin
- Recommended Changes to Critical Congenital Heart Disease Screening by Pulse Oximetry in Newborns
-